Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: A multicentre, randomized vehicle-controlled trial

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 10, 2010, Pages 1176-1182

  Korting, H C ^a   Schollmann C ^a   Cholcha, W ^b   Wolff, L ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ICHTHYOL GESELLSCHAFT   (Germany)

Author keywords

atopic eczema; children; pale sulfonated shale oil; randomized controlled trial

Indexed keywords

BITUMINOSULFONATE; GLUCOCORTICOID; ICHTHOSIN; OIL; PALE SULFONATED SHALE OIL; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CUTANEOUS PARAMETERS; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EMOLLIENTS; FEMALE; HUMANS; INFANT; MALE; QUATERNARY AMMONIUM COMPOUNDS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956308822     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03616.x     Document Type: Article

References (30)

1. Werfel T. Neurodermitis. In Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W, eds. Dermatologische Qualitätssicherung. Leitlinien und Empfehlungen, 6th edn. ABW Wissenschaftsverlag, Berlin, 2009 : 24 85.
2. Kamtsiuris P, Atzpodien K, Ellert U, Schlack R, Schlaud M. Prevalence of somatic diseases in German children and adolescents. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007 50 : 686 700.
3. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 113 : 651 657.
4. Akdis CA, Akdis M, Bieber T et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006 118 : 152 169. Erratum J Allergy Clin Immunol 2006; 118: 724.
5. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 2005 53 (2 Suppl. 2 S171 S176.
6. Biedermann T, Röcken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Invest Dermatol Symp Proc 2004 9 : 5 14.
7. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006 19 : 296 302.
8. Schmid MH, Korting HC. Coal tar, pine tar and sulfonated oil preparations: comparative activity, efficacy and safety. Dermatology 1996 193 : 1 5.
9. Schmid-Wendtner MH. Bituminosulfonate. In Korting HC, Sterry W, eds. Therapeutische Verfahren in der Dermatologie - Dermatika und Kosmetika. Blackwell Wissenschafts-Verlag, Berlin, Wien 2001 : 165 171.
10. Cholcha W, Leuschner J, Leuschner F. Untersuchungen zur Verträglichkeit von hellem sulfoniertem Schieferöl nach lokaler und systemischer Applikation. Arzneimittelforsch/Drug Res 1994a 44 : 170 177.
11. Cholcha W, Leuschner J, Leuschner F. Untersuchungen zur Verträglichkeit von dunklem sulfoniertem Schieferöl nach lokaler und systemischer Applikation. Arzneimittelforsch/Drug Res 1994b 44 : 844 849.
12. Koch R, Mays G. Orale Behandlung der Rosacea mit Natriumbituminosulfonat. Prakt Derm 1996 2 : 519 525.
13. Beckert S, Warnecke J, Zelenkova H et al. Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled multicenter study. J Vasc Surg 2006 43 : 94 100.
14. Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients treated with topical tar and artificial ultraviolet radiation. Lancet 1980 1 : 732 735.
15. Blum HF. On the mechanism of cancer induction by ultraviolet radiation. J Natl Cancer Inst 1950 11 : 463 465.
16. Czarnetzki BM. Inhibitory effects of shale oils (ICHTHYOLs) on the secretion of chemotactic leukotrienes from human leukocytes and on leukocyte migration. J Invest Derm 1986 87 : 694 697.
17. Kownatzki E, Uhrich S, Schöpf E. The effect of a sulfonated shale oil extract (ICHTHYOL) on the migration of human neutrophilic granulocytes in vitro. Arch Dermatol Res 1984 276 : 235 239.
18. Kownatzki E, Kapp A, Uhrich S. Inhibitory effect of sulfonated shale oils (ammonium bituminosulfonate) on the stimulation of neutrophilic granulocytes by the chemotactic tripeptide f-Met-Leu-Phe. Arch Dermatol Res 1986 278 : 190 193.
19. Diezel W, Schewe T, Rohde E, Rosenbach T, Czarnetzki BM. Ammoniumbituminosulfonat (Ichthyol). Antientzündliche Wirkung und Hemmung des Enzyms 5-Lipoxygenase. Hautarzt 1992a 43 : 772 774.
20. Schewe C, Schewe T, Rohde E, Diezel W, Czarnetzki BM. Inhibitory effects of sulfonated shale oils (ammonium bituminosulphonates, Ichthyols) on enzymes of polyenoic fatty acid metabolism. Arch Dermatol Res 1994 286 : 137 141.
21. Diezel W, Schulz E. Crotonöl-induziertes entzündliches Ödem und Hemmung der Entzündung durch Ammoniumbituminosulfonat (Ichthyol). Dermatol Monatssch 1991 177 : 507 508.
22. Cerinski-Hennig D, von Bruchhausen F. Hemmung der acetylierenden Bildung von PAF (Plättchen-aktivierender Faktor) durch einige Polyethylenglykole und Bituminosulfonate. Arch Pharmacol 1991 344 (Suppl. R100.
23. Warnecke J, Wendt A. Anti-inflammatory action of pale sulfonated shale oil (ICHTHYOL pale) in UVB erythema test. Inflamm Res 1998 47 : 75 78.
24. Pantke R. Bakteriologische Untersuchung von Arzneimitteln aus Schieferöl. Arzneim-Forsch/Drug Res 1965 15 : 570 573.
25. Hanifin JM. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001 10 : 11 18.
26. Niedner R. Topische Kortikosteroide versus topische Calcineurininhibitoren. Hautarzt 2003 54 : 338 341.
27. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000 4 : 1 191.
28. Luger TA. Therapie des atopischen Ekzems mit Calcineurin-Inhibitoren. In Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W, eds. Dermatologische Qualitätssicherung. Leitlinien und Empfehlungen. 6th edn. ABW Wissenschaftsverlag, Berlin, 2009 : 953 967.
29. Diezel W, Gruner S, Anhalt GJ. ATPase-positive epidermale Langerhans-Zellen: Hemmung der ATPase durch Ammoniumbituminosulfonat (Ichthyol) und Pix lithantracis. Antientzündliche Wirkung und Hemmung des Enzyms 5-Lipoxygenase. Hautarzt 1992b 43 : 22 24.
30. Gloor M, Dressel M, Schnyder UW. The effect of coal tar distillate, cadmium sulfide, Ichthyol sodium and omadine MDS on the epidermis of the guinea pig. Dermatologica 1978 156 : 238 243.